British Society for Rheumatology Biologics Register in Ankylosing Spondylitis - (BSRBR-AS)

British Society for Rheumatology Biologics Register in Ankylosing Spondylitis - (BSRBR-AS)

Duration: Data collection (2012 - 2020) (analysis ongoing)
Funder: British Society for Rheumatology
Chief investigator: Professor Gary Macfarlane
Deputy chief investigator: Professor Gareth Jones


The British Society for Rheumatology Biologics Register in Ankylosing Spondylitis (BSRBR-AS) is a study funded by the British Society for Rheumatology. We have tracked the progress of people with axial spondyloarthritis (axSpA), who were taking biologic therapy, and people who have never taken such therapy.

People with axSpA, across Scotland, England and Wales, were recruited through their local NHS rheumatology centres. Recruitment to the study started on 03 December 2012 and ended on 31 December 2017. Planned follow-up data collection stopped on the 30 June 2018, although we had one further survey during the COVID19 pandemic in mid-2020.

We asked participants to fill in questionnaires at regular intervals during their study involvement (for a maximum of five and half years), depending on the medication they were prescribed. We also asked participants to keep a study diary with changes to their medications, note of hospital admissions and referrals. The questionnaires and diary cards were sent by post to participants' homes, together with a pre-paid return envelope.

Analysis of the study is ongoing and BSRBR-AS data is also contributing to the EuroSpA collaboration, a large network of 19 registries across Europe which collect data on axSpA and/or psoriatic arthritis.

 

Further information